Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Neuranics

Explore full profile

Quantum magnetic sensors for human-machine interface applications

Glasgow, United KingdomFounded 2021Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Neuranics and the history behind them.

About Neuranics

Neuranics is a deep-tech semiconductor company founded in 2021 as the first joint spin-out from the University of Glasgow and the University of Edinburgh. The company develops high-precision, contactless magnetic sensing solutions based on Tunneling Magnetoresistance (TMR) quantum technology. This technology is designed to detect ultra-weak magnetic fields generated by the human body, such as those from the heart and muscles.

Read full description

The company was co-founded by Hadi Heidari, Professor of Nanoelectronics at the University of Glasgow (CTO); Kia Nazarpour, Professor of Digital Health at the University of Edinburgh (CSO); and Dr. Siming Zuo, an expert in electronic system design (Innovation Manager). Their collective expertise in nanoelectronics, AI, and semiconductor design formed the foundation of the company. Irish industry veteran Noel McKenna joined as CEO in 2023 to commercialize the technology.

Neuranics' business model centers on selling its sensor chips and licensing its technology to Tier-1 consumer electronics and semiconductor manufacturers. The company collaborates with these partners to integrate its solutions into their products. Its primary markets include extended reality (XR), wearable devices, digital health, and human-machine interfaces. The technology offers a low-power, scalable, and more comfortable alternative to traditional methods like electrocardiography (ECG), as it can function without direct skin contact and even through clothing.

The core products include patented TMR sensors, custom Application-Specific Integrated Circuits (ASICs), and AI-enabled hardware and software. Neuranics offers a development kit for its Magnetocardiography (MCG) technology, allowing partners to test and integrate the sensors for applications like 24/7 heart monitoring. Another key application is Magnetomyography (MMG) for gesture recognition, which can interpret fine muscle movements in the forearm for controlling robotics or interacting with virtual environments.

Source: Dealroom company data

At a glance

Founded
2021
Headquarters
Glasgow, United Kingdom
Sector
Health Tech & Medtech

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • Par Equity
  • Blackfinch Ventures
  • Old College Capital
  • University of Glasgow
  • Archangels
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom96.2%
🇮🇪 Ireland3.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Neuranics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Neuranics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.